Midday Report: Agios (AGIO) Shares Up on June 23

Equities Staff  |

Shares of Agios Pharmaceuticals Inc (NASDAQ: AGIO) climbed 6.88% Thursday.

As of 11:46:22 est, Agios sits at $19.85 and has risen $1.28 per share.

Agios has moved 11.81% over the last 30 days and has a YTD change of 43.41% based on the previous close.

The company is set to release earnings on 2022-07-28.

For technical charts, analysis, and more on Agios visit the company profile.

About Agios Pharmaceuticals Inc

Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.

To get more information on Agios Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Agios Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content